Effects of Nalmefene on Reduction of Drinking Alcohol and Improvement of Liver Function/Quality of Life in Patients with Alcoholic Liver Disease Treated mainly by Hepatologists
Not Applicable
- Conditions
- Alcoholic Liver Injury, Alcohol Dependence
- Registration Number
- JPRN-UMIN000048182
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of hypersensitivity to the nalmefene component. Patients receiving opioids (analgesics, anesthetics) or within 1 week of discontinuation of opioid therapy Patients with acute symptoms of opioid dependence or withdrawal Patients who wish to be excluded from the study, Patients who cannot provide written consent Patients experiencing withdrawal symptoms, depressive symptoms or suicide attempts. Patients deemed inappropriate by the attending physician or principal/assistant investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method